Showing 5011-5020 of 5403 results for "".
- Caliber Imaging & Diagnostics Receives $1.4 Million Order for VivaScope® Systems From European Distributor MAVIG GmbHhttps://practicaldermatology.com/news/20140114-caliber_imaging__diagnostics_receives_14_million_order_for_vivascope_systems_from_european_distributor_mavig_gmbh/2459373/Caliber Imaging & Diagnostics (OTCQB:LCDX), formerly Lucid, Inc., announces receipt of $1.4 million in orders for VivaScope® systems from its European distributor MAVIG GmbH. These units are scheduled to be shipped in the first half of 2014. MAVIG has been Caliber's exclusive distributor in Europe f
- FDA Approves Combination Use of GSK's Mekinist® (trametinib) and Tafinlar® (dabrafenib)https://practicaldermatology.com/news/20140109-fda_approves_combination_use_of_gsks_mekinist_trametinib_and_tafinlar_dabrafenib/2459375/GlaxoSmithKline plc [LSE/NYSE: GSK] has received FDA approval of Mekinist® (trametinib) for use in combination with Tafinlar® (dabrafenib) for the treatment of patients with unresectable melanoma or metastatic melanoma with BRAF V600E or V600K mutation
- NeXeption, LLC Forms New Company Alexar Therapeutics, Inc. to Develop Novel LXR Agonist Portfolio for Dermatologic Indicationshttps://practicaldermatology.com/news/20140102-nexeption_llc_forms_new_company_alexar_therapeutics_inc_to_develop_novel_lxr_agonist_portfolio_for_dermatologic_indications/2459383/NeXeption, LLC, a biopharmaceutical management company that brings together product opportunities, management expertise and funding to reach compelling partnership milestones, has secured $21.5 million in Series A financing to form Alexar Therapeutic
- NYC's Eric Schweiger, MD Launches Book on Acne Treatmenthttps://practicaldermatology.com/news/20131230-nycs_eric_schweiger_md_launches_book_on_acne_treatment/2459384/New York City dermatologist Eric Schweiger, MD has launched his new book: 100 Acne Tips & Solutions: The Clear Clinic Guide to Perfect Skin, available December 2013 on
- Cutera Appoints Scott Ashworth as Executive Vice President of Global Saleshttps://practicaldermatology.com/news/20131230-cutera_appoints_scott_ashworth_as_executive_vice_president_of_global_sales/2459385/Scott Ashworth recently joined Cutera as Executive Vice President of Global Sales. He brings twenty-five years of experience in building and leading global sales and marketing teams focused on commercialization of products, establishing distributio
- First Practice in Northwest Adopts ARTAS® Robotic Systemhttps://practicaldermatology.com/news/20131230-first_practice_is_northwest_adopts_artas_robotic_system/2459386/Advanced Hair Restoration of Bellevue, WA has installed the revolutionary ARTAS® Robotic System — the first and only FDA-cleared, physician-controlled, computer-assisted techno
- Valeant Pharmaceuticals to Acquire Solta Medicalhttps://practicaldermatology.com/news/20131216-valeant_pharmaceuticals_to_acquire_solta_medical/2459394/Valeant Pharmaceuticals International, Inc. announced that it has entered into a definitive agreement to acquire all of the outstanding common stock
- Topical Nitric Oxide Shows Promisehttps://practicaldermatology.com/news/20131212-topical_nitric_oxide_shows_promise/2459395/Novan is kicking off a two-year program to support the pharmaceutical development of Nitric Oxide Advanced Healing (NOAH) technology, including formulation work, nonclinical toxicology, and proof of concept studies in models of deep partial-thickness and full-thickness thermal injuries. The
- Cosmetic Surgery Forum Kicks Off in Las Vegashttps://practicaldermatology.com/news/20131206-cosmetic_surgery_forum_kicks_off_in_las_vegas/2459397/The fifth annual Cosmetic Surgery Forum got underway yesterday in Las Vegas, Nevada, highlighted by varied educational sessions and discussion among faculty, attendees, and residents. Among the offerings from the first day were 75 resident presentations, practice management pearls, live injections,
- FDA Clears Scar Management Gel from Oculus and Quinnovahttps://practicaldermatology.com/news/20131204-fda_clears_scar_management_gel_from_oculus_and_quinnova/2459398/Oculus Innovative Sciences, Inc. has received a new 510(k) clearance from the FDA for Microcyn Scar Management HydroGel, for the management of old and new hypertrophic and keloid scarring resulting from burns, general surgical procedures, and trauma wounds. Oculus U.S. dermatology partner, Quinnova